Atossa Therapeutics (ATOS) Change in Receivables (2011 - 2015)
Atossa Therapeutics (ATOS) posted quarterly Change in Receivables of -$1.9 million for Q4 2015, down 6906.98% year-over-year from $27601.0 in Q4 2014, and down 242.94% quarter-over-quarter from $1.3 million in Q3 2015.
Atossa Therapeutics (ATOS) Change in Receivables (2011 - 2015) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Change in Receivables for 5 consecutive years, with -$1.9 million the latest figure, recorded in Q4 2015.
- In Q4 2015, Change in Receivables fell 6906.98% year-over-year to -$1.9 million; the TTM figure through Sep 2015 stood at $1.9 million (up 3111.78% YoY), while the FY2014 annual figure was -$1450.0, down 100.41% from the prior year.
- Change in Receivables declined to -$1.9 million in Q4 2015 per ATOS's latest filing, from $1.3 million in the prior quarter.
- Across five years, Change in Receivables topped out at $1.3 million in Q3 2015 and bottomed at -$1.9 million in Q4 2015.
- Historically, Change in Receivables has averaged $28825.5 across 5 years, with a median of -$2872.0 in 2012.
- On a YoY basis, Change in Receivables climbed as much as 45534.53% in 2015 and fell as far as 9902.5% in 2015.
- Atossa Therapeutics' Change in Receivables stood at -$1224.0 in 2011, then slumped by 2656.7% to -$33742.0 in 2012, then decreased by 1.5% to -$34247.0 in 2013, then soared by 180.59% to $27601.0 in 2014, then slumped by 6906.98% to -$1.9 million in 2015.
- Business Quant data shows ATOS's Change in Receivables at -$1.9 million in Q4 2015, $1.3 million in Q3 2015, and -$636359.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -1.88 Mn |
| Dec 31, 2015 | -1.88 Mn |
| Sep 30, 2015 | 1.31 Mn |
| Sep 30, 2015 | 1.31 Mn |
| Jun 30, 2015 | -636,359.00 |
| Jun 30, 2015 | -636,359.00 |
| Mar 31, 2015 | 1.20 Mn |
| Mar 31, 2015 | 1.20 Mn |
| Dec 31, 2014 | 27,601.00 |
| Dec 31, 2014 | 27,601.00 |
| Sep 30, 2014 | -2,893.00 |
| Sep 30, 2014 | -2,893.00 |
| Jun 30, 2014 | -6,362.00 |
| Jun 30, 2014 | -6,362.00 |
| Mar 31, 2014 | -19,796.00 |
| Mar 31, 2014 | -19,796.00 |
| Dec 31, 2013 | -34,247.00 |
| Dec 31, 2013 | -34,247.00 |
| Sep 30, 2013 | 7,755.00 |
| Sep 30, 2013 | 7,755.00 |